Lo said he expects to find other mechanisms of resistance in the remaining 60 percent of relapsing patients where neither of the two new mechanisms were found.
其他60%的复发病人的耐药机制与以上两种均不相同,Lo说他希望能在他们身上找到其他的耐药机制。
For patients with metastatic melanoma, like those in the Jonsson Cancer Center study, there are few effective treatments, so it's vital to come up with alternative therapies, Lo said.
对于黑素瘤转移病人来说,就像在琼森癌症中心的研究中的一样,有效药物少之又少。 因此,加紧研究替代性治疗方法是至关重要的。
应用推荐